Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

18.2%

2 terminated/withdrawn out of 11 trials

Success Rate

77.8%

-8.7% vs industry average

Late-Stage Pipeline

18%

2 trials in Phase 3/4

Results Transparency

0 of 7 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

5(50.0%)

Phase 1

2(20.0%)

Phase 3

2(20.0%)

Phase 2

1(10.0%)

10Total

N/A(5)

Phase 1(2)

Phase 3(2)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (11)

Showing 11 of 11 trials

NCT04129203Not ApplicableUnknown

Versi Retriever Approving Trial in Japan

Role: lead

NCT01702584Unknown

Efficacy and Safety of StENt-assisted Treatment for CErebral Aneurysms

Role: lead

NCT01261234Not ApplicableCompleted

Carotid Artery Stenting With Cilostazol Addition for Restenosis

Role: lead

NCT01516658Not ApplicableCompleted

HYdrogel Coil Versus Bare Platinum Coil in Recanalization Imaging Data Study

Role: lead

NCT03366818Not ApplicableCompleted

New Stent Retriever, VERSI System for AIS

Role: lead

NCT02200354Phase 2Terminated

The Safety and Efficacy of Pemetrexed Rechallenge With Bevacizumab

Role: lead

NCT02907229Not ApplicableCompleted

Safety and Efficacy of Honeycomb Microporous Covered Stents (NCVC-CS1) for the Treatment of Intracranial Aneurysms

Role: collaborator

NCT00333164Phase 3Completed

Cilostazol-Aspirin Therapy Against Recurrent Stroke With Intracranial Artery Stenosis

Role: collaborator

NCT00221182Phase 1Terminated

Stem Cell Study for Patients With Heart Disease

Role: collaborator

NCT00221156Phase 3Completed

Acarbose and Secondary Prevention After Coronary Stenting

Role: collaborator

NCT00221143Phase 1Completed

Stem Cell Study for Patients With Leg Ulcer/Gangrene

Role: collaborator

All 11 trials loaded